MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-05-0000265
Sphaera Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹7.73 Cr
▲ 6% YoY
Net profit · FY 2024
₹1.35 Lakh
Net margin 0.2%
EBITDA · FY 2024
₹23.83 Lakh
EBITDA margin 3.1%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.25 Cr
Issued & subscribed
Company age
19 yrs
Est. 2007
Employees · EPFO
43
Provident fund records
Directors on board
3
As per MCA filings
About Sphaera Pharma Private Limited
Data last updated:
Sphaera Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 30 November 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2007PTC224934. Its GSTIN is 06AALCS3747G1Z5 (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.25 Cr. It is led by directors including Somdutta Sen and Abhinav Dhandia.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No.1A 2 3 6 7 – A 2nd Floor Indure House, Savitri Cinema Complex Greater Kailash II New Delhi, Delhi, India – 110048.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.73 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.35 Lakh (net margin 0.2%) and EBITDA of ₹23.83 Lakh (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 13% over five years.
The company has about 43 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sphaera Pharma. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹16.87 Cr; the latest was in September 2012. Its 3 peer companies in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 2 larger and 1 smaller; the largest is Notrox Research Private Limited with revenue of ₹8.18 Cr. The company has 13 MSME Form 1 returns on record between 2019 and 2024, listing 554 overdue payments to 34 micro and small suppliers.
Sphaera Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0000265). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sphaerapharma.com.
Company details
CIN U24232DL2007PTC224934
Registration Number 224934
Incorporation Date 30 November 2007
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-05-0000265
CIN history
Sphaera Pharma has one previous CIN (Corporate Identification Number): U24232RJ2007PTC025401. The current CIN is U24232DL2007PTC224934, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232DL2007PTC224934 | Current |
| U24232RJ2007PTC025401 | Previous |
Recognitions & Rankings of Sphaera Pharma
Contact details
Sphaera Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is sphaerapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressOffice No.1A 2 3 6 7 – A 2nd Floor Indure House, Savitri Cinema Complex Greater Kailash II New Delhi, Delhi, India – 110048
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Sphaera Pharma Private Limited, buy the company report.
Comprehensive company report
Sphaera Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sphaera Pharma operates one associated brand: Sphaera Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specialty company engaged in drug discovery and development | sphaerapharma.com |
Business activity
The main business activity of Sphaera Pharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Sphaera Pharma Private Limited, buy the company report.
Financials of Sphaera Pharma Private Limited
FY 2025 filings availableSphaera Pharma Private Limited reported revenue of ₹7.73 Cr (up 6% YoY) for FY 2024.
Revenue · FY 2024
₹7.73 Cr ▲ 6%
Net profit · FY 2024
₹1.35 Lakh margin 0.2%
EBITDA · FY 2024
₹23.83 Lakh margin 3.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▼ 13%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 102%
3 years · compounded
▼ 59%
5 years · compounded
▼ 13%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 6% growth in the latest year. EBITDA rose 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.83 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sphaera Pharma Private Limited, buy the company report.
Board of directors of Sphaera Pharma Private Limited
Sphaera Pharma has 3 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Somdutta Sen Also directs: Sanctai Technology Private Limited | Director | 02 Dec 2022 | 3 Years 10 Months | Current |
| Abhinav Dhandia Also directs: Dhandia Jewellers LLP, Sphaera Pharma Research and Development Private Limited, Cyro Healthcare Private Limited and 3 more | Director | 21 Feb 2019 | 7 Years 8 Months | Current |
| Ashish Dugar | Director | 02 Dec 2022 | 3 Years 10 Months | Current |
Peer comparison
Sphaera Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Notrox Research Private Limited | ₹8.18 Cr (FY 2024) | -15.0% | Bangalore, Karnataka, India | |||
| Infinia Sciences Private Limited | ₹8.07 Cr (FY 2025) | 6.0% | Pune, Maharashtra, India | |||
| Sphaera Pharma Private Limitedthis company | ₹7.73 Cr (FY 2024) | ₹1.35 Lakh | 0.2% | 6.0% | 43 | New Delhi, Delhi, India |
| Spectrum Clinical Research Private Limited | ₹7.52 Cr (FY 2024) | 19.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Sphaera Pharma Private Limited, buy the company report.
Auditor
Sphaera Pharma Private Limited is audited by KJAG & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KJAG & Associates | FY 2023 | 026179N |
Shareholding
The shareholding of Sphaera Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sphaera Pharma Private Limited, buy the company report.
Deals & funding
Sphaera Pharma Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹16.87 Cr; the latest was in September 2012.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹16.87 Cr
Deals on record (1 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2012 | Secondary share transfer | Undisclosed | Buyer: Sphaera Pharma Pte Ltd Seller: an individual |
To see the full deal history of Sphaera Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Sphaera Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Sphaera Pharma Private Limited has 13 MSME Form 1 returns on record between 2019 and 2024, listing 554 overdue payments to 34 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 34)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Nextgen Life Sciences Private Limited | |||
| Clearsynth Labs Limited | |||
| an individual supplier | |||
| Agm Group |
To see the full MSME payment records of Sphaera Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Sphaera Pharma has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Sphaera Pharma Private Limited has a workforce of 43 employees on its EPFO records as of Mar 21, 2024, across 1 active EPFO establishment.
Employee count
43
Active EPFO establishments
1
Employee growth
-14%
GST
Sphaera Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AALCS3747G1Z5 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sphaera Pharma Private Limited, buy the company report.
Recent activity
Sphaera Pharma Private Limited has 16 board changes on record since 2008: 3 appointments and 13 cessations. The latest: Kritika Chhabra ceased to be Company Secretary on 31 May 2024.
AGM
Sphaera Pharma Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Sphaera Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Kritika Chhabra ceased to be Company Secretary.
Ceased
Ashish Dugar ceased to be Additional Director.
Ceased
Somdutta Sen ceased to be Additional Director.
Appointed
Ashish Dugar was appointed as Director.
Ceased
Bhuwan Kumar Chaturvedi ceased to be Director.
Ceased
Ramachandran Srinivasan ceased to be Director.
Appointed
Somdutta Sen was appointed as Director.
Ceased
Varun Batra ceased to be Additional Director.
Ceased
Kamal Singh Dugar ceased to be Director.
Ceased
Abhinav Dhandia ceased to be Additional Director.
7 earlier events are in the company report.
News
Frequently asked questions
Sphaera Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 30 November 2007 (19+ years old) and is registered under CIN U24232DL2007PTC224934.
Sphaera Pharma has 3 current directors:
- Somdutta Sen - Director
- Abhinav Dhandia - Director
- Ashish Dugar - Director
The latest financial statements of Sphaera Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sphaera Pharma is 06AALCS3747G1Z5, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Sphaera Pharma is U24232DL2007PTC224934. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sphaera Pharma was incorporated on 30 November 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
Sphaera Pharma has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹16.87 Cr; the latest was in September 2012.
The peers of Sphaera Pharma by revenue are Notrox Research Private Limited, Infinia Sciences Private Limited, Spectrum Clinical Research Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Kritika Chhabra ceased to be Company Secretary on 31 May 2024. Ashish Dugar ceased to be Additional Director on 28 Sep 2023. Somdutta Sen ceased to be Additional Director on 28 Sep 2023. Sphaera Pharma has 16 board changes on record in total.
Yes, Sphaera Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-HR-05-0000265).
Sphaera Pharma has 13 MSME Form 1 returns on record between 2019 and 2024, listing 554 overdue payments to 34 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Sphaera Pharma can be reached through the website sphaerapharma.com. Its registered office is in New Delhi, Delhi, India.